---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-052216"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T05:02:34.906014+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology appoints Francisco Olivera as acting Principal Accounting Officer (Feb 18, 2022)

## Summary
- Appointment made effective February 18, 2022, on an interim basis while a formal CFO search is conducted.
- Olivera currently serves as VP of Finance, joined the company in 2019, and has over a decade of biotech experience.
- He played a key role in the IPO, Series B financing, and acquisition of Amplify Medicines.
- No arrangements or understandings exist with any other person regarding the appointment; no related party transactions reported.

## SEC filing metadata
- accession: 0001193125-22-052216
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/d305562d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-052216
- JSON: https://secwatch.observer/filing/0001193125-22-052216.json
- Plain text: https://secwatch.observer/filing/0001193125-22-052216.txt

## Key facts
- Executive change
  Francisco Olivera was appointed as acting Principal Accounting Officer at ImageneBio, Inc..
  - Action: appointed
  - Role: acting Principal Accounting Officer
  source text: On February 18, 2022, the Board of Directors (the “Board”) of Ikena Oncology, Inc. (the “Company”) unanimously appointed Francisco Olivera as the acting Principal Accounting Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm
- Executive change
  Douglas R. Carlson resigned as other_named_officer at ImageneBio, Inc..
  - Action: resigned
  source text: This appointment has been made in connection with the effectiveness of the resignation of Douglas R. Carlson, as previously disclosed on January 28, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.